Nanobiotechnology in Drug Delivery: How Nanoparticles are Revolutionizing Targeted Cancer Treatment

This project gives step‑by‑step guidance for analyzing nanobiotechnology‑based drug delivery systems that target cancer. Traditional cancer treatments like systemic chemotherapy and radiation often lack selectivity, causing serious side effects and limited effectiveness. To fix these problems, the study looks at and models how different nanoparticle carriers—liposomes, polymeric nanoparticles, and metal‑based nanocarriers—move through the body. It examines two ways tumors can be targeted: passive buildup through the Enhanced Permeability and Retention (EPR) effect, and active targeting using surface ligands that bind to specific cancer‑cell receptors. Using computational models and side‑by‑side comparisons, the project measures key factors such as drug‑loading efficiency, release rate, how quickly the body clears the carrier, and ways

to beat multidrug resistance. The resulting framework is a detailed resource that shows how changes to nanocarriers can improve drug solubility and lower systemic toxicity, providing a systematic method for designing more effective, personalized delivery systems. This review‑driven modeling approach helps undergraduate researchers optimize nanomedicine formulations.

Message: Hi FE, I need help with “Nanobiotechnology in Drug Delivery: How Nanoparticles are Revolutionizing Targeted Cancer Treatment” in “Biotechnology & Biomedical Engineering”